<?xml version="1.0" encoding="UTF-8"?>
<p id="p0010">Up to mid-2018, 2229 laboratory-confirmed cases of MERS-CoV infection were reported to the World Health Organization (WHO) from 27 countries (
 <xref rid="b0040" ref-type="bibr">Middle East respiratory syndrome coronavirus (MERS-CoV) WHO MERS Global Summary and Assessment of Risk Global summary, 2018</xref>). Majority of the cases were reported by Saudi Arabia, with cases reported from other countries in the Middle East, North Africa, Europe, the United States of America, and Asia (
 <xref rid="b0040" ref-type="bibr">Middle East respiratory syndrome coronavirus (MERS-CoV) WHO MERS Global Summary and Assessment of Risk Global summary, 2018</xref>). This has directed the development of stringent screening criteria that has been implemented in different health care systems in Saudi Arabia; including Ministry of Health hospitals. A suspected case which defined as an instance of admission to a health care facility with any clinical symptoms that suggest infection or a history of contact with established cases, will trigger a laboratory MERS-CoV testing using real-time polymerase chain reaction (RT-PCR) test for MERS-CoV in swab samples collected at admission (
 <xref rid="b0005" ref-type="bibr">Aleanizy et al., 2017</xref>).
</p>
